Valeant Ruling May Pave Way For Patent-Based FCA Suits
By Joshua Robbins and Rick Taché · March 5, 2024, 3:26 PM EST
In Silbersher v. Valeant Pharmaceuticals International Inc., a generic-drug maker challenged the validity of Valeant's patent before the Patent Trial and Appeal Board and won, with a finding that Valeant got...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login